Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00473161 · ClinicalTrials.gov registry record
Use of Surface Electromyography Biofeedback to Improve Reaching in Children With Cerebral Palsy
A clinical trial, sponsored by University of Southern California.
- Completed
- Registry status
- 20
- Enrollment target
NCT00473161: Completed study, sponsored by University of Southern California.
NCT00473161 is a clinical trial that has completed, run by University of Southern California. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00473161 has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
A newly-developed device for biofeedback of surface EMG will be used to either increase or decrease activity in the muscles of children with poor reaching due to cerebral palsy.
Interventions
- DEVICE surface EMG biofeedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2007-05 |
What the finished NCT00473161 record still lists
NCT00473161 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which surface EMG biofeedback is the first listed.
NCT00473161 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00473161 about?
NCT00473161 is a clinical study titled "Use of Surface Electromyography Biofeedback to Improve Reaching in Children With Cerebral Palsy". A newly-developed device for biofeedback of surface EMG will be used to either increase or decrease activity in the muscles of children with poor reaching due to cerebral palsy.
What is the current status of trial NCT00473161?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2007-05.
What interventions are being tested in trial NCT00473161?
The interventions under investigation include: surface EMG biofeedback (DEVICE).
Who is sponsoring clinical trial NCT00473161?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia